Luminex Corp (LMNX.OQ)

LMNX.OQ

About

Luminex Corporation (Luminex)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The Company’s Multi-Analyte Profiling (xMAP) technology, an open architecture, multiplexing technology, allows simultaneous analysis of up to 500... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.66
Market Cap (Mil.):	$796.53
Shares Outstanding (Mil.):	42.01
Dividend:	--
Yield (%):	--

Financials

	LMNX.OQ	Industry	Sector
P/E (TTM):	123.91	76.48	34.28
EPS (TTM):	0.15	--	--
ROI:	2.44	4.18	18.85
ROE:	2.53	9.09	19.72

Latest News about LMNX.OQ

» More LMNX.OQ News

Competitors

	Price	Change
Affymetrix, Inc. (AFFX.OQ)	$3.67	-0.01
Life Technologies Corp. (LIFE.OQ)	$74.04	+0.10
Becton, Dickinson and Co. (BDX.N)	$100.83	+0.66
Illumina, Inc. (ILMN.OQ)	$70.31	-0.77
Sequenom, Inc. (SQNM.OQ)	$4.03	-0.05
Abbott Laboratories (ABT.N)	$37.76	+0.28
Cepheid (CPHD.OQ)	$38.09	-0.14
Johnson & Johnson (JNJ.N)	$86.82	-0.39
Roche Holding Ltd. (ROG.VX)	CHF253.10	+2.40
Siemens AG (SIEGn.DE)	€82.45	+1.16

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - LUMINEX CORPORATION (LMNX-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of LUMINEX CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. Provider: Jefferson Research	$20.00 Buy
ValuEngine Detailed Valuation Report for LMNX Provider: ValuEngine, Inc.	$127.00 Buy
Luminex Corporation (LMNX) - Medical Equipment - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy
LUMINEX CP (LMNX) 12-months forecast Provider: Pechala's Reports	$15.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.